Medtronic

2247 articles with Medtronic

• Medtronic Canada Named on List of Canada's Greenest Employers in 2021

  4/22/2021

  Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE: MDT) — the world's largest medical technology, services, and solutions company — has been named on the 2021 list of Canada's Greenest Employers.

• Medtronic Receives U.S. FDA Approval for Pipeline™ Flex Embolization Device with Shield Technology™

  4/21/2021

  Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received approval from the United States Food and Drug Administration (FDA) for Pipeline™ Flex Embolization Device with Shield Technology™

• IN.PACT™ AV Drug-Coated Balloon Is First and Only to Show Superior and Sustained Results Through Two Years Compared to PTA in Treating Arteriovenous Fistulae Lesions

  4/20/2021

  Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the safety and effectiveness results through 24 months for the IN.PACT AV Access clinical study.

• 

  BioSpace Global Roundup: Boehringer Ingelheim Launches Weight-Loss Trials for NASH

  4/15/2021

  Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.

• Medtronic Canada Named Top 50 Great Places To Work™ and Best Workplaces™ for Women

  4/14/2021

  Medtronic Canada ULC, a subsidiary of Medtronic plc — the world's largest medical technology, services, and solutions company — has been named on the 2021 lists of Top 50 Great Places to Work in Canada and Best Workplaces™ for Women for the second consecutive year after a thorough and independent analysis conducted by Great Place to Work®.

• U.S. FDA Grants De Novo Clearance for First and Only Artificial Intelligence System for Colonoscopy; Medtronic Launches GI Genius™ Intelligent Endoscopy Module

  4/12/2021

  - The GI Genius ™  Module Assists Physicians in Detecting Pre-Cancerous Growths; Potentially Addressing 19 Million Colonoscopies Annually - Transformative AI Colorectal Cancer Prevention  Platform Expands Medtronic Capabilities in Medical Technology Data Analytics and Insights

• Medtronic Announces Ongoing Initiatives to Address Health Equity for People of Color Living with Diabetes

  4/7/2021

   Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its ongoing commitment to health equity for people of color living with diabetes.

• The Medtronic Foundation and Children's Heartlink Focus New Partnership on Health Equity for 10,000 Children and 10,000 Health Workers in Underserved Countries

  4/7/2021

  The $2.5 Million USD Multi-Year Partnership Builds Capacity to Provide Pediatric Heart Surgery to 10,000 Children and Trains 10,000 Health Workers in Brazil, India, and China.

• Medtronic Receives FDA Approval for Breakthrough Transcatheter Pulmonary Valve Replacement for Patients with Congenital Heart Disease

  3/26/2021

  Harmony™ Transcatheter Pulmonary Valve is First Minimally Invasive Alternative for Patients with Severe Pulmonary Regurgitation Who Have a Native or Surgically-Repaired Right Ventricular Outflow Tract

• Medtronic Receives CE Mark Approval for SenSight™ Directional Lead System for DBS Therapy

  3/22/2021

   Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the CE (Conformité Européenne) Mark for the SenSight™ directional lead system for Deep Brain Stimulation (DBS) therapy as treatment of symptoms

• Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2021

  3/8/2021

  The board of directors of Medtronic plc (NYSE: MDT) on Friday, March 5, 2021 , approved the fiscal year 2021 fourth quarter cash dividend of $0.58 per ordinary share, representing a 7.4 percent increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in May 2020. 

• Medtronic Announces First Procedures in Pivotal Trial to Evaluate Novel Ablation Technology in Treating Atrial Fibrillation

  3/4/2021

  Medtronic plc, the global leader in medical technology, announced the first procedures in the investigational device exemption pivotal trial to evaluate the PulseSelect™ Pulsed Field Ablation System, a novel, breakthrough technology that uses pulsed electric fields to treat atrial fibrillation.

• Medtronic Reports Third Quarter Fiscal 2021 Financial Results

  2/23/2021

  - Q3 Revenue of $7.8 Billion Increased 0.8% as Reported and Decreased 1.0% Organically -  Q3 GAAP Diluted EPS of $0.94 ; Q3 Non-GAAP Diluted EPS of $1.29

• Medtronic Receives FDA Approval for Expanded MRI Labeling of InterStim™ SureScan™ MRI Leads

  2/18/2021

  Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received approval from the United States Food and Drug Administration (FDA) for expanded MRI labeling of its InterStim™ II and InterStim™ Micro sacral neuromodulation (SNM) systems that use SureScan™ MRI leads.

• Medtronic Announces Voluntary Recall of Unused Valiant Navion™ Thoracic Stent Graft System

  2/17/2021

  Medtronic plc, the global leader in medical technology, has voluntarily issued a global recall of unused Medtronic Valiant Navion™ thoracic stent graft system and informed physicians to immediately cease use of the device until further notice.

• Medtronic Executives to Speak at Upcoming Investor Conferences

  2/17/2021

  Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the following upcoming investor conferences, with its executives answering questions about the company:

• Surgeons Complete First Procedures Across the U.S. Utilizing Medtronic's Midas Rex™ Drills and Navigated Disc Prep and Interbodies with the Mazor™ Robotic Guidance System

  2/16/2021

  Dr. Gregory Poulter of OrthoIndy , Dr. Sharad Rajpal of Boulder Neurosurgical & Spine Associates and Dr. Eiman Shafa of Twin Cities Spine Center Are First in the U.S. to Complete Surgeries Using the Most Comprehensive Integrated Spine Surgery Platform Available

• Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021

  2/16/2021

   Medtronic plc (NYSE:MDT) announced today that it will report financial results for its third quarter of fiscal year 2021 on Tuesday, February 23, 2021 . A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at https://newsroom.medtronic.com .

• New Study in Newborns Finds Nellcor™ Pulse Oximetry Technology Provides Faster Stable Oxygen Saturation Readings Than Masimo Pulse Oximeter

  2/9/2021

  Nellcor™ Pulse Oximetry Technology Demonstrated Statistically Significant Difference in Time to Deliver a Stable Oxygen Saturation Value and Heart Rate

• Medtronic Announces Early Site Release of New Radial Artery Access Portfolio Following First-in-Patient Procedure

  2/1/2021

  Acquisition of RIST Neurovascular Enhances Medtronic's Capabilities to Serve Patients Treated for Brain Aneurysms and Other Neurovascular Conditions